| What is the optimum perioperative drug therapy following lower-extremity vein bypass surgery? | |
| | |
MedLine Citation:
|
PMID: 20006805 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
While endoluminal procedures are now commonly done for symptomatic peripheral arterial disease, vein bypass remains the gold standard for revascularization. Lower extremity vein bypass procedure success is dependent on patient factors, surgical judgment and technique, including use of medications. Cardioprotective medications have proven efficacy to decrease morbidity and mortality, but their use to improve graft patency is less well known. We review the up to date use of medications with known vascular effects that may promote graft success, as well as decrease cardiovascular events in this high risk patient group. |
| | |
Authors:
|
Peter Henke |
Related Documents
:
|
3775465 - Coagulase-negative staphylococcal endocarditis: a view from the community hospital. 17022195 - Greater palatine island axial pattern flap for repair of oronasal fistula related to eo... 6403785 - Complications of co2 laser surgery of the larynx. 12149175 - Neutropenic enterocolitis. 9024865 - Ultrastructure of sensory endings in diplostomum pseudospathaceum niewiadomska, 1984 ce... 16881945 - Low literacy impairs comprehension of prescription drug warning labels. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Seminars in vascular surgery Volume: 22 ISSN: 1558-4518 ISO Abbreviation: Semin Vasc Surg Publication Date: 2009 Dec |
Date Detail:
|
Created Date: 2009-12-17 Completed Date: 2010-06-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8809602 Medline TA: Semin Vasc Surg Country: United States |
Other Details:
|
Languages: eng Pagination: 245-51 Citation Subset: IM |
Affiliation:
|
Section of Vascular Surgery, University of Michigan, Ann Arbor, MI, USA. henke@umich.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anticholesteremic Agents
/
therapeutic use Anticoagulants / therapeutic use Antihypertensive Agents / therapeutic use Biological Markers / metabolism Clinical Protocols Graft Occlusion, Vascular / drug therapy* Humans Inflammation / metabolism Leg / blood supply* Perioperative Care Peripheral Vascular Diseases / surgery* Platelet Aggregation Inhibitors / therapeutic use Vascular Patency* Vascular Surgical Procedures / methods Vasodilator Agents / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Anticholesteremic Agents; 0/Anticoagulants; 0/Antihypertensive Agents; 0/Biological Markers; 0/Platelet Aggregation Inhibitors; 0/Vasodilator Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hybrid procedures and distal origin grafts.
Next Document: Detection of imminent vein graft occlusion: what is the optimal surveillance program?